- Home
- PLX vs OIO Comparison
PLX vs OIO Comparison
Compare PLX & OIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.37
Company Overview
Basic Information| Metric | PLX | OIO |
|---|---|---|
| Founded | 1993 | 1999 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.4M | 139.7M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLX | OIO |
|---|---|---|
| Price | $2.37 | $2.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 641.2K | 24.4K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $36.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.82 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.36 | $1.50 |
| 52 Week High | $3.19 | $7.50 |
Technical Indicators
Market Signals| Indicator | PLX | OIO |
|---|---|---|
| Relative Strength Index (RSI) | 64.79 | 50.38 |
| Support Level | $2.06 | $1.65 |
| Resistance Level | $2.42 | $7.50 |
| Average True Range (ATR) | 0.10 | 0.28 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 83.38 | 58.34 |
Price Performance
Historical Comparison PLX
OIO
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.